TrialHaematologica2014

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.

Roland B Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.